A Closed Fund Watchlist
For contrarians only.
For contrarians only.
A fund closing to new investors is rarely a permanent move. Eventually the fund will face enough outflows to prompt it to reopen. That's often a wonderful contrarian buying opportunity. If you only like funds with hot three-year returns, avert your eyes because hot funds don't reopen.
Every once in a while a fund will be closed for so long that it needs to reopen because its existing shareholder base is in redemption mode. More often than an aging shareholder base, the cause is a slump in performance. So, you've got to be a bit of a contrarian to hop on the reopening. I've selected six Morningstar Medalists that are good bets to reopen in the next couple of years. So, add the ones you like to your watchlist, and they might become available.
Royce Premier (RYPRX) has a Morningstar Analyst Rating of Gold, but it has been in a slump. Poor five-year returns have led to $1.3 billion in outflows at this $6.6 billion fund. But we have confidence in Chuck Royce and Whitney George. They look for low debt levels and fundamentals like solid return on invested capital and free cash flow. By Royce standards, the 50-70 stock portfolio is concentrated.
ASTON/TAMRO Small Cap has seen only a modest $240 million go out the door over the past 12 months. However, the fund has only $963 million left, so it may be the best bet on this list to reopen in the near future. Managers Philip Tasho and Tim Holland meld earnings growth and valuations into a tame small-growth portfolio. The fund's long-term record remains strong even though 2013 was a dud.
Lazard Emerging Markets Equity (LZOEX) has produced outstanding returns over all the trailing time periods, yet it has seen $900 million in outflows. It still has $16 billion in assets under management, so I think it's less likely to reopen, but take a close look if it does. James Donald's mild-mannered but flexible value strategy has been quite consistent: The fund has outperformed peers in eight of the past 10 years.
Perkins Small Cap Value (JSCVX) hasn't been open for a long time, but it's currently in one of its downward ebbs, so keep your eyes peeled. The Perkins crew runs a focused value style that produces solid long-term results and occasional slumps. The folks who make out like bandits are the ones who buy after the slumps rather than after the rallies. The fund has lost about a third of its assets the past year--it's now down to $1.9 billion in assets.
Fidelity Small Cap Value (FCPVX) is one of my favorite Fidelity funds. Chuck Myers runs a focused Buffett-style small-cap fund that really behaves differently from most other Fidelity funds, making it a good diversifier for those with all-Fidelity portfolios. With $900 million in outflows the past 12 months, this fund might reopen come 2015.
AllianzGI NFJ Small-Cap Value got a little larger than management wanted, and the firm went so far as to cull a portion of its 401(k) business. That tells me it may let assets shrink a bit more before reopening. Still, this $7.7 billion fund has shed $1.3 billion in the past 12 months ended July 2014, and that's a fair amount to handle. The fund has a Silver Analyst Rating as it still has the same excellent strategy and management it's had all along. Yes, its three-year Morningstar Return ranking is weak, but it's in the top 10% for the trailing 10 years, and its dividend-oriented strategy is a good one.
FundInvestor Newsletter | ||
Want to hear more from the mutual fund experts? Subscribe to Morningstar FundInvestor for exclusive research, coveted analysis and proprietary ratings—neatly packaged and delivered to your inbox. | One-Year Digital Subscription 12 Issues | $125 Premium Members: $115 Easy Checkout |
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.